Senzime AB announced its largest hospital win to date. The leading Houston-based university hospital system win consists of more than 250 TetraGraph systems for use at multiple hospitals with planned use on up to 100,000 patients per year. The TetraGraph is an advanced neuromuscular monitoring system used by anesthesiologists at over 200 leading hospitals across the globe to help improve patient safety during and after surgery.

The TetraGraph meets the requirements of the new US and European clinical guidelines. The system accurately guides clinicans to secure the right dose of neuromuscular blocking drugs and their antagonists, as well as indicate when it is safe to allow patients to breathe on their own again after surgery. The win is the result of a comprehensive clinical and competitive product evaluation with the potential to be used on 100,000 patients per year.